Metraipolis › archive › dc_aa0fb5cf610f

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis — Europe PMC PMID:40698082

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40698082
DOI
10.3389/fimmu.2025.1585556
License (as archived)
solo-consultazione
Archived
2026-10-07T15:50:55.133Z
SHA-256 of the archived text
840ec2fb4e17ba41b5281a6b5b632d863b2b48a41ce6ce32773929eb750a60b4
Stable URL of this page
https://metraipolis.com/documento/dc_aa0fb5cf610f

How to cite

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis — Europe PMC PMID:40698082 — Europe PMC (en), https://europepmc.org/article/MED/40698082 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa0fb5cf610f (Metraipolis archive dc_aa0fb5cf610f, sha256 840ec2fb4e17ba41b5281a6b5b632d863b2b48a41ce6ce32773929eb750a60b4)
BibTeX
@misc{dcaa0fb5cf610f,
  title = {Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis — Europe PMC PMID:40698082},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40698082},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa0fb5cf610f; sha256 840ec2fb4e17ba41b5281a6b5b632d863b2b48a41ce6ce32773929eb750a60b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40698082. Agents can read the archived copy with the MCP tool read_document.